miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

por NISHIJIMA, NOBUHIKO, SEIKE, MASAHIRO, SOENO, CHIE, CHIBA, MIKA, MIYANAGA, AKIHIKO, NORO, RINTARO, SUGANO, TEPPEI, MATSUMOTO, MASARU, KUBOTA, KAORU, GEMMA, AKIHIKO
Publicado 2016

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer

por Nakamichi, Shinji, Seike, Masahiro, Miyanaga, Akihiko, Chiba, Mika, Zou, Fenfei, Takahashi, Akiko, Ishikawa, Arimi, Kunugi, Shinobu, Noro, Rintaro, Kubota, Kaoru, Gemma, Akihiko
Publicado 2018

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

por Takahashi, Akiko, Seike, Masahiro, Chiba, Mika, Takahashi, Satoshi, Nakamichi, Shinji, Matsumoto, Masaru, Takeuchi, Susumu, Minegishi, Yuji, Noro, Rintaro, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko
Publicado 2018